NH TherAguix
NH TherAguix is a biotechnology company developing nanoparticle-based theranostic products for cancer treatment. Its lead product, AGuIX, is a theranostic nano-drug designed to improve the efficacy of radiotherapy for cancer patients. The company has developed a pipeline of drugs targeting brain metastases, lung cancer, pancreatic cancer, and cervical cancer. The theranostic approach combines therapeutic and…
Funding snapshot
About
NH TherAguix is a biotechnology company developing nanoparticle-based theranostic products for cancer treatment. Its lead product, AGuIX, is a theranostic nano-drug designed to improve the efficacy of radiotherapy for cancer patients. The company has developed a pipeline of drugs targeting brain metastases, lung cancer, pancreatic cancer, and cervical cancer. The theranostic approach combines therapeutic and diagnostic capabilities within a single nanoparticle, enabling simultaneous treatment and imaging of Founded in 2015 and headquartered in Lyon, France, the company has raised $15.9M in Series A funding from investors including Bpifrance, Supernova Invest, Financiere Arbevel, and Omnes Capital.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drugs > Cancer,
Oncology > Drugs > Diversified
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Statiq
Statiq is a manufacturer of electric vehicle charging hardware and operator of charging networks across India.
PhotoRoom
PhotoRoom is an AI-powered photo editing and product photography platform designed for e-commerce businesses of all sizes.
Moises
Moises is an AI-powered creative suite for musicians that provides tools for practice, performance, creation, and collaboration.
Krisp Technologies
Krisp is an AI-powered voice platform that provides noise cancellation, accent conversion, meeting assistance, and voice AI solutions for individuals, call centers, and developers.